Fluocinolone
Fluocinolone (fluocinolone acetonide) is a corticosteroid used on the skin for atopic dermatitis and other inflammatory, itchy skin conditions, in the ear for chronic eczematous external otitis, and as an eye implant for diabetic macular edema and chronic non-infectious uveitis.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 33 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Fluocinolone is a moderate-strength corticosteroid that calms inflammation and itch, used mostly on the skin for eczema and similar rashes, and also as an ear oil and long-acting eye implants. It is a familiar standby, on the market since the 1960s and available generically. Used sparingly, the skin forms are well tolerated, and most people notice little beyond mild burning, dryness or irritation where it goes on. The thing to watch is overuse, because heavy or prolonged use, especially under bandages, can thin the skin (sometimes permanently) and let enough steroid absorb to suppress the body’s own adrenal hormones, which matters most in children.
Clinical pearls
- The body oil and ear oil contain refined peanut oil, so mention any peanut allergy before using them.
- Keep the oil off the face, armpits and groin, and never use it in a child’s diaper area.
- Stop once the rash is under control, and call your prescriber if it is not clearly better within 2 weeks.
- Report any vision change promptly, since steroids, especially the eye implants, can raise eye pressure and cause cataracts.
Patient information guide A plain-language walkthrough of Fluocinolone, written from its FDA label.
What Fluocinolone is used for
▾
Fluocinolone is a corticosteroid with several uses depending on the product.
- Fluocinolone creams, ointments and topical solutions (including Synalar): relieve inflammation and itching from corticosteroid-responsive dermatoses.
- Fluocinolone topical oil and Derma-Smoothe/FS Body Oil: atopic dermatitis in adults, and moderate to severe atopic dermatitis in children 3 months and older for up to 4 weeks.
- Ear oils (Dermotic, Flac Otic Oil, fluocinolone acetonide oil): chronic eczematous external otitis in adults and children 2 years and older.
- Iluvien implant: diabetic macular edema in people previously treated with steroids without a significant rise in eye pressure, and chronic non-infectious uveitis of the back of the eye.
- Yutiq and Retisert implants: chronic non-infectious uveitis affecting the back of the eye.
How Fluocinolone works
▾
Corticosteroids reduce inflammation. They limit swelling, blood vessel widening, white blood cell movement and scar formation. They are thought to block phospholipase A2, which reduces the body's production of inflammatory chemicals like prostaglandins and leukotrienes.
Fluocinolone dosage
▾
Dosing differs by product, so follow your prescriber and label.
- Creams and ointments: generally a thin film two to four times daily. Hair should be parted at hairy sites.
- Topical oil: adults apply three times daily; children moisten the skin first and apply twice daily for up to 4 weeks.
- Ear oil: 5 drops in the affected ear twice daily for 7 to 14 days.
- Eye implants: placed by an eye specialist, by injection (Iluvien, Yutiq) or surgery (Retisert).
Stop the oils once the condition is controlled, and contact your provider if there is no improvement in 2 weeks.
Dosing details from the FDA-approved label
From the Fluocinolone prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Iluvien intravitreal implant: ophthalmic intravitreal injection
- For ophthalmic intravitreal injection under aseptic conditions
- Implant placed inferior to the optic disc and posterior to the equator of the eye, 4 millimeters inferotemporal from the limbus
- Yutiq intravitreal implant: ophthalmic intravitreal injection
- For ophthalmic intravitreal injection under aseptic conditions
- Implant placed inferior to the optic disc and posterior to the equator of the eye, 4 millimeters inferotemporal from the limbus
- Retisert intravitreal implant
- Surgically implanted into the posterior segment of the affected eye through a pars plana incision
- One tablet of 0.59 mg of fluocinolone acetonide
- Designed to release at a nominal initial rate of 0.6 mcg/day, decreasing over the first month to a steady state between 0.3-0.4 mcg/day over approximately 30 months
- May be replaced following depletion of fluocinolone acetonide as evidenced by recurrence of uveitis
- Fluocinolone acetonide topical oil: adult patients
- Apply as a thin film to the affected areas three times daily
- Discontinue use when control of disease is achieved within 2 weeks or contact the healthcare provider if no improvement is seen within 2 weeks
- Fluocinolone acetonide topical oil: pediatric patients
- Moisten skin and apply to affected areas twice daily for up to 4 weeks
- Do not apply to the diaper area
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION • Fluocinolone acetonide topical oil is not for oral, ophthalmic, or intravaginal use. ( 2.1 ) • Do not use on face or intertriginous areas. ( 2.1 ) • Adult patients: Apply to affected areas 3 times daily. ( 2.2 ) • Pediatric patients: Moisten skin and apply to affected areas twice daily for up to 4 weeks. ( 2.3 ) 2.1 Important Administration Instructions Fluocinolone acetonide topical oil is for topical use only. Not for oral, ophthalmic, or intravaginal use. Apply the least amount of fluocinolone acetonide topical oil needed to cover the affected areas. Discontinue use when control of disease is achieved within 2 weeks or contact the healthcare provider if no improvement is seen within 2 weeks. Do not use on the face, axillae, or groin unless directed by the healthcare provider. Do not apply to intertriginous areas due to the increased risk of local adverse reactions [see Adverse Reactions ( 6 ) and Use in Specific Populations ( 8.4 )] . Do not apply to the diaper area; diapers or plastic pants may constitute occlusive use [see Warnings and Precautions ( 5.1 )] . 2.2 Recommended Dosage in Adults Apply fluocinolone acetonide topical oil as a thin film to the affected areas three times daily . 2.3 Recommended Dosage in Pediatric Patients Moisten skin and apply fluocinolone acetonide topical oil as a thin film to the affected areas twice daily for up to four weeks .
Read the full Dosage and Administration section on DailyMed →
Fluocinolone side effects
▾
Side effects vary by form. Skin and ear products can cause local reactions.
Common side effects
- Skin thinning (atrophy) and stretch marks (striae)
- Burning, itching, irritation or dryness
- Acne-like breakouts or inflamed hair follicles
- Lighter skin patches (hypopigmentation)
- Allergic skin reaction (allergic contact dermatitis)
- Eye implants: cataract and raised eye pressure
- Eye implants: eye pain, floaters, bleeding on the eye surface
- Acne-like breakouts, folliculitis
When to get medical help
- Call your doctor if your skin condition does not improve within 2 weeks, or if it gets worse.
- Report any vision changes, since steroids can raise the risk of glaucoma and cataract.
- Call your doctor if you notice signs of too much steroid absorbed into the body, such as slowed growth or delayed weight gain in a child.
- Tell your doctor if a skin infection develops or worsens, as steroids can delay healing.
- Stop the topical oil and get help for signs of an allergic reaction, such as hives or itching, especially if you are sensitive to peanuts.
- After an eye implant, get help for eye pain, vision loss or signs of infection, as pressure and infection (endophthalmitis) need monitoring.
Call your doctor for vision changes, signs of infection, signs of steroid effects throughout the body, or worsening of your condition.
Fluocinolone warnings and precautions
▾
The main risk of topical steroids is absorption into the body, causing adrenal suppression, Cushing's syndrome and high blood sugar. Children are at higher risk. Large areas, long use, bandage coverings, damaged skin, liver failure and young age increase absorption.
- Local reactions such as skin thinning may sometimes be irreversible.
- Steroids can raise the risk of glaucoma and cataract. Keep topical oil away from eyes.
- Steroids can delay healing or worsen skin infections.
- Topical oil contains refined peanut oil.
- Plastic bandage films may be flammable and can pose a suffocation risk for children.
Fluocinolone interactions
▾
The label gives limited interaction information.
- Using more than one steroid-containing product at once can increase total steroid exposure.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Fluocinolone
▾
- Iluvien must not be used with active or suspected eye infections, glaucoma with a high cup-to-disc ratio, or known allergy to its components.
- Be cautious with peanut sensitivity when using the topical oil.
- Children are more susceptible to whole-body effects.
- Topical oils: not established under 3 months. Ear oils: ages 2 and older.
- Pregnancy: use the smallest area for the shortest time.
- Breastfeeding: use the smallest area for the shortest time and avoid the nipple and areola.
- Liver failure can increase absorption.
Fluocinolone overdose
▾
Topical steroids can be absorbed enough to cause effects throughout the body, even with normal use. Contact your doctor or poison control if you suspect you've used too much.
What Fluocinolone does in the body
▾
Fluocinolone topical oil is low to medium in strength compared with other topical steroids. In children treated twice daily for 4 weeks, some aged 2 to 5 had low morning cortisol, but all responded normally to testing.
How your body processes Fluocinolone
▾
Topical steroids can be absorbed through healthy skin. Absorption is higher with inflamed skin, bandage coverings and certain formulations. Once absorbed, they are broken down mainly in the liver and cleared by the kidneys, and some leave through bile.
How to store Fluocinolone
▾
Store at room temperature 15-25°C (59-77°F); avoid freezing and excessive heat above 40°C (104°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Fluocinolone: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Fluocinolone — the kind of thing our pharmacy team would talk through with you at the counter.
What is this medicine for?
▾
How should I use the skin product?
▾
How do I use the ear oil?
▾
Can I use it on my face or in skin folds?
▾
What side effects should I watch for?
▾
Is it safe in pregnancy or for children?
▾
Is Fluocinolone available over the counter?
▾
When was Fluocinolone first available?
▾
Who makes Fluocinolone?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Fluocinolone on HelloPharmacist
Fluocinolone forms and strengths (how it comes)
Fluocinolone is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Fluocinolone inactive ingredients by manufacturer.
Topical cream, ointment or gel
How this form is used
- Synalar cream and ointment relieve inflammation and itching from corticosteroid-responsive dermatoses.
- Derma-Smoothe/FS Body Oil treats atopic dermatitis in adults and moderate to severe atopic dermatitis in children 3 months and older.
- Fluocinolone acetonide cream and ointment are generally applied as a thin film two to four times daily.
- Derma-Smoothe/FS: adults apply three times daily; children moisten skin and apply twice daily for up to 4 weeks.
- Derma-Smoothe/FS is not for the face, skin folds, eyes, mouth or vagina unless directed by your provider.
Ear drops
How this form is used
- Dermotic, Flac Otic Oil and fluocinolone acetonide ear oil treat chronic eczematous external otitis in adults and children 2 years and older.
- Fluocinolone acetonide ear oil: tilt head, pull the ear lobe back and up, and use the supplied dropper to apply 5 drops.
- Dermotic: stay tilted about a minute, then pat away excess with a clean cotton ball.
- Dermotic: used twice daily for 7 to 14 days, stopping when controlled within 2 weeks.
- Dermotic is for the ear only, not for the mouth, eyes or vagina.
Eye drops
How this form is used
- Iluvien treats diabetic macular edema in people previously treated with steroids without a significant rise in eye pressure.
- Iluvien treats chronic non-infectious uveitis affecting the back of the eye.
- Yutiq treats chronic non-infectious uveitis affecting the back of the eye.
- Retisert treats chronic non-infectious uveitis affecting the back of the eye.
- Iluvien and Yutiq are given by an eye doctor as an injection into the eye under sterile conditions.
- Retisert is surgically implanted into the back of the eye.
- After Iluvien or Yutiq injection, eye pressure and infection are monitored.
Topical solution
How this form is used
- Fluocinolone acetonide topical solution relieves inflammation and itching from corticosteroid-responsive dermatoses.
Insert or device
Fluocinolone on the U.S. market: products, makers and brands
How Fluocinolone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
19 companies list 46 Fluocinolone product records with the FDA, mostly as topical cream, ointment or gel, ear drops, eye drops; the earliest marketing or approval year on record is 1963. Brand names on the directory include Synalar, Capex, DermOtic and 10 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (8) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Fluocinolone is used (Medicaid data)
A general measure of how commonly Fluocinolone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Fluocinolone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Fluocinolone prescribed? Of the 1,601 medications we measure, Fluocinolone ranks #317 by Medicaid prescriptions — more than 80% of them.
Utilization by Fluocinolone product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
fluocinolone acetonide 0.1 MG/ML Topical Oil Most dispensed
Summed across the 10 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1191307
fluocinolone acetonide 0.1 MG/ML Otic Solution
Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1191299
fluocinolone acetonide 0.1 MG/ML Topical Solution
Summed across the 3 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1191310
fluocinolone acetonide 0.00025 MG/MG Topical Ointment
Summed across the 6 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1191256
fluocinolone acetonide 0.1 MG/ML Topical Cream
Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1191302
fluocinolone acetonide 0.25 MG/ML Topical Cream
Summed across the 4 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1191315
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Fluocinolone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 31 of 85 listed Fluocinolone NDCs with Medicaid activity.
Compare Fluocinolone products
A representative set of FDA-listed product records for Fluocinolone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Ear drops | ||||
| 0.11 mg/mL | Auricular (otic) | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 0.11 mg/mL | Auricular (otic) | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 0.11 mg/mL | Auricular (otic) | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 0.11 mg/mL | Auricular (otic) | Patrin Pharma, Inc. | ANDA | View NDC → |
| 0.11 mg/mL | Auricular (otic) | Quagen Pharmaceuticals LLC | ANDA | View NDC → |
| 0.11 mg/mL | Auricular (otic) | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 0.11 mg/mL | Auricular (otic) | Royal Pharmaceuticals | NDA | View NDC → |
| 💊Eye drops | ||||
| 0.18 mg | Intravitreal | ANI Pharmaceuticals, Inc. | NDA | View NDC → |
| 0.19 mg | Intravitreal | ANI Pharmaceuticals, Inc. | NDA | View NDC → |
| 0.59 mg | Intravitreal | Bausch & Lomb Incorporated | NDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 0.01 mg/100 mL | Topical | A-S Medication Solutions | ANDA | View NDC → |
| 0.11 mg/mL | Topical | A-S Medication Solutions | ANDA | View NDC → |
| 0.11 mg/118.28 mL | Topical | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 0.1 mg/g | Topical | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.25 mg/g | Topical | ANI Pharmaceuticals, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.01 mg/100 mL | Topical | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 0.11 mg/mL | Topical | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 0.1 mg/g | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.25 mg/g | Topical | Cosette Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 0.25 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.11 mg/mL | Topical | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 0.25 mg/g | Topical | Medimetriks Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 0.01 mg/100 mL | Topical | Padagis Israel Pharmaceuticals Ltd × 2 listings | ANDA | View NDC → |
| 0.11 mg/mL | Topical | Quagen Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 0.11 mg/mL | Topical | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 0.11 mg/mL | Topical | Royal Pharmaceuticals | NDA | View NDC → |
| 0.11 mg/mL | Topical | Royal Pharmaceuticals, LLC | NDA | View NDC → |
| 0.11 mg/118.28 mL | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 💊Topical solution | ||||
| 0.1 mg/mL | Topical | Actavis Pharma, Inc. | ANDA | View NDC → |
| 0.1 mg/mL | Topical | Fougera Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.1 mg/mL | Topical | Lupin Pharmaceuticals,Inc. | ANDA | View NDC → |
| 0.1 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
Showing 46 of 46 products — FDA National Drug Code Directory. See every product, package size and price: browse all 46 Fluocinolone NDCs →
Fluocinolone side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Fluocinolone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Fluocinolone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Fluocinolone FDA approval history
How Fluocinolone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Fluocinolone recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 2 Fluocinolone recalls since July 2021. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 Lots: Lot #: AD81290, AD81291, AD81292 and AD81293, Exp. Date 1/31/2027 FDA record D-0256-2026 →
- Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Village: Kishanpura, Baddi Nalagarh Road, District… Lots: Lot #: 05220346, 05220369 Exp 1/31/ 2024; 05220582, Exp 2/29/2024; 05220861 Exp 3/31/2024 FDA record D-0259-2024 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 25126 8 dose forms · 14 strengths
-
Dose form (SCDF) Drug Implant RxCUI 584152In current FDA listingsClinical drug / strength (SCD) acetonide 0.18 MGRxCUI 2099361acetonide 0.19 MGRxCUI 1552351acetonide 0.59 MGRxCUI 1191323 -
Dose form (SCDF) Medicated Shampoo RxCUI 377518In current FDA listingsClinical drug / strength (SCD) acetonide 0.1 MG/MLRxCUI 1191265 -
Dose form (SCDF) Otic Solution RxCUI 603749In current FDA listingsClinical drug / strength (SCD) acetonide 0.1 MG/MLRxCUI 1191299 -
Dose form (SCDF) Topical Cream RxCUI 377894In current FDA listingsClinical drug / strength (SCD) acetonide 0.025 MG/MLRxCUI 1191346acetonide 0.0625 MG/MLRxCUI 1191348acetonide 0.1 MG/MLRxCUI 1191302acetonide 0.25 MG/MLRxCUI 1191315 -
Dose form (SCDF) Topical Gel RxCUI 377993In current FDA listingsClinical drug / strength (SCD) acetonide 0.00025 MG/MGRxCUI 1191344 -
Dose form (SCDF) Topical Oil RxCUI 385106In current FDA listingsClinical drug / strength (SCD) acetonide 0.1 MG/MLRxCUI 1191307 -
Dose form (SCDF) Topical Ointment RxCUI 372221In current FDA listingsClinical drug / strength (SCD) acetonide 0.0000625 MG/MGRxCUI 1191339acetonide 0.00025 MG/MGRxCUI 1191256 -
Dose form (SCDF) Topical Solution RxCUI 374426In current FDA listingsClinical drug / strength (SCD) acetonide 0.1 MG/MLRxCUI 1191310
Look up RxCUI 25126 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Fluocinolone supply and shortage status
Whether Fluocinolone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Fluocinolone costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Oil · Topical | 0.01 mg/100 mL | $0.171 per mL | NDC details & price history |
| Oil · Topical | 0.11 mg/118.28 mL | $0.175 per mL | NDC details & price history |
| Oil · Auricular (otic) | 0.11 mg/mL | $1.32 per mL | NDC details & price history |
| Ointment · Topical | 0.25 mg/g | $0.571–$1.26 per gram | NDC details & price history |
| Cream · Topical | 0.25 mg/g | $1.01–$1.39 per gram | NDC details & price history |
| Cream · Topical | 0.1 mg/g | $1.20–$1.71 per gram | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Fluocinolone brand names
Fluocinolone is sold under 13 brand names in the FDA directory — Synalar, Capex, DermOtic, Derma-Smoothe FS and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Fluocinolone: manufacturers and labelers
19 companies list Fluocinolone products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, ANI Pharmaceuticals, Inc., Cosette Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Fluocinolone drug class (RxNorm)
Fluocinolone belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Fluocinolone page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Medimetriks Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →